Aurora has received all necessary regulatory approvals to launch the study, which will include data from 40 single-level and 40 multilevel cases, according to a June 28 press release.
The Dexa-C system is the first in a series of implants based on Aurora’s patented Dexa technology platform, which includes implants varying in density to best match a patient’s bones.
Dexa-C is intended for use on patients who require anterior cervical discectomy and fusion surgery, implanting an interbody spacer into the cervical intervertebral body space to stabilize and fuse the level.
